Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plexpress Secures $2.3M to Commercialize TRAC High-Content Gene Expression Analysis Platform

Published: Thursday, April 19, 2012
Last Updated: Thursday, April 19, 2012
Bookmark and Share
Company targets applications including companion diagnostics and ADMET.

Plexpress has announced follow-on funding of up to $2.3M to commercialize its novel TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-content gene expression analysis.

The investment has been secured to commercialize the technology internationally, build up the ADMET screening service and develop TRAC specifically within the oncology sector.

Existing investors - Conor Technology Fund, VTT Ventures, Aloitusrahasto Vera and the Helsinki University Fund - as well as Tekes, the Finnish Funding Agency for Technology and Innovation, have invested $1.4M initially with further milestone payments of up to $900k.

As the potential applications and opportunities in genomic research continue to grow, the TRAC system is poised to provide the ideal method for the increased throughput and multiplex screening that the development of new therapies and diagnostics requires.

With TRAC, the expression of up to 30 genes can be routinely quantified in each plate well (30-plex), while thousands of samples can be processed quickly, easily and reproducibly.

The TRAC technology has been refined and validated over 10 years of development, initially at the Technical Research Centre of Finland, VTT, and subsequently at Plexpress, with over 50 separate projects completed successfully.

By avoiding the need for RNA extraction, cDNA conversion and amplification, the TRAC protocol takes only four hours to complete and RNA degradation is significantly reduced. This makes it fast, simple and cost-effective to implement, while lowering error rates and maximizing accuracy.

“This funding will enable Plexpress to pursue high value market opportunities, such as companion diagnostics and ADMET. TRAC provides significant benefits over existing technologies such as qPCR and microarrays, which do not offer either the throughput or the multiplexing that many genomics researchers require. Our early investors recognized these opportunities and have underlined their belief in TRAC with this continuing funding”, said Plexpress CEO, and leading expert in TRAC technology, Dr Jari Rautio.

Commenting on the renewed funding, MoB Managing Partner, Jari Mieskonen, of Conor Venture Partners said: “We are very happy that all current investors continued to support Plexpress in this follow-on investment round. The added involvement of Tekes gives us increased leverage for commercializing the TRAC technology and with the extremely positive feedback from key customers we foresee a fast market roll-out.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!